This study is designed to determine outcome for patients with 5 or more central nervous system (CNS) metastatic lesions treated with stereotactic radiosurgery (SRS).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
MD Anderson Cancer Center at Cooper
Camden, New Jersey, United States
Overall survival
Time frame: 6 months
Distant CNS free survival (new lesions in CNS)
Time frame: 6 months
Quality of life (as determined by FACT-Br)
Time frame: 6 months
Local control (For CNS, local control refers to treated lesions)
Time frame: 6 months
Timing and need for salvage therapy (whole brain radiation or repeat whole brain radiation)
Time frame: 6 months
Median dose to whole brain with SRS
Time frame: 6 months
Neurocognitive testing (Montreal Cognitive Assessment)
Time frame: 6 months
Adverse Events for Safety and Tolerability of treatment
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.